 |
| Image: securingpharma.com |
Journalist, Christina England, is not letting go of GlaxoSmithKline. Her latest article has summed up the year 2010 for them. She mentions various vaccines of Glaxo that are not all what they seem and the recent Avandia and Seroxat scandals.
She writes:
GlaxoSmithKline the drug giants, have spent the last few days trying to stay off the bottom of the FTSE 100, especially after the UK's Medicines and Healthcare Products Regulatory Agency said that it's diabetes treatment Avandia should be pulled from sale, over concerns that it can lead to heart attacks in some patients. This came at a particularly difficult time for GlaxoSmithKline and was yet another nail in their coffin, as Pandemrix, their vaccine for the swine flu, is currently also under the magnifying glass, having been suspended by Finland, Sweden, Poland and Nepal, due to a growing number of reports of adverse reactions.
Christina is a UK journalist with an HND in journalism. She is also a member of ICAP International Coalition of Advocates for the People.
Her article, 'Vaccine suspensions and drug disasters has made 2010 a annus horribilis for GlaxoSmithKline', can be read in full HERE
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: